Unlisted ANI Pharmaceuticals Inca, a speciality and generic pharmaceutical company is listing through the purchase of BioSante Pharmaceuticals, another drugmaker, in an all-stock deal.

BioSante will issue stock to ANI shareholders giving ANI stockholders a 53% stake in the combined company.

The combined company will be renamed ANI Pharmaceuticals and be led by the ANI management team, with Arthur Przybyl serving as chief executive officer, the companies said in a joint statement.